WHO gives nod to first-ever Malaria drug tailored for infants; major breakthrough achieved in child healthcare

Malaria drug for infants: Global child health has received a shot in the arm, as the World Health Organization (WHO) has granted prequalification approval to the first-ever Malaria treatment, specifically designed for infants and newborns.  The drug, named artemether-lumefantrine, is the first antimalarial formulation tailored exclusively for the youngest and most susceptible patients affected by the mosquito-borne disease. Till now, infants and babies were treated by means of…

Read more

Continue reading